- Home
- WPRT vs ALGS Comparison
WPRT vs ALGS Comparison
Compare WPRT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WPRT | ALGS |
|---|---|---|
| Founded | 1995 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1M | 34.6M |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WPRT | ALGS |
|---|---|---|
| Price | $1.85 | $6.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.38 | ★ $39.33 |
| AVG Volume (30 Days) | 65.7K | ★ 124.6K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,186,000.00 |
| Revenue This Year | N/A | $32.20 |
| Revenue Next Year | $28.74 | $4.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.54 | $3.98 |
| 52 Week High | $2.68 | $13.69 |
Technical Indicators
Market Signals| Indicator | WPRT | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 51.83 |
| Support Level | $1.83 | $6.36 |
| Resistance Level | $2.11 | $6.91 |
| Average True Range (ATR) | 0.05 | 0.58 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 97.22 | 41.23 |
Price Performance
Historical ComparisonAbout WPRT Westport Fuel Systems Inc
Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three reportable segments: High-Pressure Controls, Heavy-Duty OEM, and Cespira. It derives maximum revenue from Heavy-Duty OEM segment. Heavy-Duty OEM segment's products include HPDI related fuel system solutions and components. Geographically, the company operates in Europe, America and Asia, of which it generates maximum revenue from Europe. It also develops and supplies advanced LPG, CNG, LNG and H2 systems and components for OEM (original equipment manufacturer) D-OEM (delayed oem) and After Market (retrofit market) world-wide.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.